Full-Time

Product Manager

Commercial Solutions

Posted on 10/3/2025

Deadline 10/1/26
Hinge Health

Hinge Health

1,001-5,000 employees

Digital clinic delivering tech-enabled physical therapy

Compensation Overview

$150.4k - $225.6k/yr

+ Equity

San Francisco, CA, USA

Hybrid

Hybrid role requires in-office 3 days per week at the San Francisco office.

Category
Product (1)
Required Skills
Observability
Data Analysis
Requirements
  • 4+ years in Product Management (or equivalent), including ownership of operations/workflow automation products or internal platforms used by Go-To-Market and Customer Success teams at scale
  • Proven ability to convert qualitative time sink problems into deterministic workflows and measurable time savings, and to ship incrementally toward a long-term vision
  • Prior experience instrumenting workflow automations end-to-end (events, observability, SLAs, and governance)
  • Experience with enterprise-grade workflow and integration stacks across core Commercial systems (CRM, customer success platforms, scheduling, analytics) to automate cross-system workflows; comfortable partnering with data teams on embedded analytics and scalable data pipelines
  • Strong cross-functional leadership with Customer Success, Implementation, Design, Data, and Engineering; able to build rigorous operating cadences and drive clarity through complexity
  • Excellent product writing (PRDs and technical design documents), prioritization, and stakeholder management, with a bias to ship and measure
Responsibilities
  • Define and drive the strategy and roadmap for Customer Success workflow automation and data plumbing across the Commercial lifecycle, translating opportunities into phased product deliveries tied to measurable outcomes
  • Convert operational pain points into clear product requirements (PRDs), experiments, and iterative rollouts that reduce manual effort and improve client retention
  • Lead discovery with Customer Success, Implementation, and Research and Development to standardize metrics, templates, and playbooks so they can be automated, measured, and continuously improved
  • Partner with Engineering and Data to ship reliable integrations and automations across core Commercial systems (e.g., CRM, communications, scheduling, analytics), with built-in observability and resilience
  • Establish and maintain data contracts and operational standards that make workflows auditable, extensible, and scalable across different use cases
  • Incrementally develop buyer-facing capabilities that create client value while minimizing Customer Success overhead
  • Build and run a durable operating cadence—backlog management, prioritization, stakeholder program reviews, launch checklists, and post-launch measurement—to ensure consistent execution and impact
  • Stay up-to-date on industry trends, emerging technologies, and competitive landscape to inform product strategy
Desired Qualifications
  • Background in Commercial tooling, Customer Success Operations, or data products serving customer-facing teams
  • Familiarity with buyer-facing client portal patterns and incremental rollout strategies that reduce Customer Success overhead

Hinge Health runs a digital clinic for joint and muscle care, delivering physical therapy through a mobile app and a clinical care team. Users follow personalized exercise programs, track progress, and communicate with their care team while learning about their condition. Revenue comes from partnerships with employers and health plans that cover the service, making it free for users. The platform blends clinician-guided care with technology to make physical therapy accessible and scalable beyond traditional clinics.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

San Francisco, California

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Migraine Care Program targets $78B employer market with 125 clients covering 2M lives already.
  • Q1 2026 revenue grew 47% YoY to $182M with 85% gross margins and strong cash generation.
  • Client base expanded 23% to 2,849 employers and health plans with 52% billings growth.

What critics are saying

  • Client growth slowed to 23% YoY while revenue grew 47%, indicating unsustainable pricing dependency.
  • Omada Health and Kaia Health directly compete for employer contracts with lower-cost integrated platforms.
  • Cefaly Technology's established migraine devices threaten Enso's $78B market expansion and 2M-life program.

What makes Hinge Health unique

  • Enso's hybrid form impulse therapy delivers 54.7% pain reduction versus 25.3% for placebo devices.
  • Integrated digital clinic combines wearable device, exercise therapy, and expert clinician guidance in one app.
  • FDA-cleared for both musculoskeletal pain and migraine using trigeminal-nerve neuromodulation technology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive compensation with meaningful equity

Medical, Dental, Vision, Disability and Life Insurance (We cover 100% of your premium and 75% for your dependents)

Flexible PTO

FSA/HSA accounts

Family & fertility benefit through Maven Clinic

401(k) match

3 months paid parental leave

Professional Development budget

Quarterly lifestyle benefit to use towards WFH equipment & fitness

Generous mental health stipend

Work from home policy

Opportunity to join a fantastically talented, diverse, and passionate team at a pivotal time in the company's lifecycle

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

1%

2 year growth

-1%
Yahoo Finance
Apr 6th, 2026
Hinge Health director sells 50,000 shares for $1.9M under pre-set trading plan

Gabriel M.I. Mecklenburg, a director at Hinge Health, sold 50,000 Class A Common Stock shares for approximately $1.92 million on 1 April 2026, according to an SEC Form 4 filing. The shares were sold at a weighted average price of $38.46, in line with the market close price of $38.49. The transaction was executed under a Rule 10b5-1 trading plan adopted in December 2025. The sale reduced Mecklenburg's direct Class A holdings to zero, though he continues to hold 3,268,813 Class B shares, which are convertible to Class A shares. Hinge Health, a digital musculoskeletal care platform, has a market capitalisation of $3.07 billion. Shares have risen 23% over the past year but declined 15% year to date.

Business Wire
Mar 17th, 2026
Hinge Health adds Freshworks CFO Tyler Sloat to board of directors

Hinge Health has appointed Tyler Sloat to its board of directors. Sloat currently serves as Chief Financial Officer and Chief Operating Officer at Freshworks, overseeing finance, IT, security and corporate strategy. Sloat brings nearly three decades of operational leadership in high-growth technology companies. He previously served as CFO at Zuora, guiding the company through its 2018 IPO, and held senior positions at NetApp and Siebel Systems. He has also served on the boards of Oanda Corporation and Compass Healthcare. Hinge Health, which went public on the NYSE, provides AI-powered musculoskeletal care using wearable devices and clinical expertise. The San Francisco-based company aims to improve patient outcomes whilst reducing healthcare costs for clients.

Yahoo Finance
Feb 11th, 2026
Hinge Health stock jumps 15% on Q4 beat with $170.7M revenue and 46% growth

Hinge Health shares surged 15% on Wednesday after the healthcare platform beat fourth-quarter earnings expectations. The company reported earnings of $0.49 per share on sales of $170.7 million, surpassing analyst forecasts of $0.43 per share on $156.8 million in revenue. The wearable device and AI-powered health advice provider, which treats musculoskeletal conditions, posted 46% year-over-year sales growth in the quarter. Net profit increased more than 360%, whilst free cash flow rose 65% to $61.5 million. For full-year 2025, Hinge reported 51% sales growth with 80% gross margins and $179.6 million in free cash flow. The company forecasts 39% sales growth for first-quarter 2026 and 25% annual growth to approximately $737 million, with non-GAAP earnings expected to grow 29%.

Business Wire
Feb 10th, 2026
Hinge Health posts 46% Q4 revenue growth to $171M, raises 2026 guidance

Hinge Health, a digital musculoskeletal care company, reported fourth-quarter revenue of $170.7 million, up 46% year-over-year, and full-year 2025 revenue of $587.9 million, up 51%. The company achieved non-GAAP operating income of $48 million in Q4, more than doubling from $21.4 million in the prior year. For full-year 2025, Hinge Health generated $171.4 million in operating cash flow and $179.6 million in free cash flow, nearly tripling from 2024. The company added clients to reach 2,830 total, with 25 million contracted lives and nearly 783,000 members. Hinge Health provided 2026 guidance of $732 million to $742 million in revenue and $151 million to $156 million in non-GAAP operating income. The company repurchased $65 million in shares during Q4 under its $250 million buyback programme authorised in November 2025.

Fierce Healthcare
Aug 6th, 2025
Hinge Health reports 55% revenue growth

Hinge Health reported a 55% revenue growth in Q2 2025, reaching $139 million, surpassing Wall Street's $125 million expectation. Shares rose 18% post-IPO, with a 52% increase from the $32 IPO price. Despite a net loss of $576 million, the company achieved a non-GAAP operating income of $26.1 million. Hinge projects Q3 revenue between $141 million and $143 million and full-year 2025 revenue between $548 million and $552 million. The HingeSelect provider network aims for a 2026 launch.

INACTIVE